⚕ GalenOps CRO console
← SITE007 (JPN)

SITE007-0362

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE007 (JPN) (Dr. Dubois) · consented 2023-05-03
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Grade 1 Pruritus — outcome: RECOVERED/RESOLVED; onset 2023-07-20 (study day 70); relationship: not assessed

severe assessed 2026-08-18

Grade 3 Alanine aminotransferase increased — outcome: RECOVERED/RESOLVED; onset 2023-08-24 (study day 105); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-09-22 (study day 134); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-11-17 (study day 190); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-12-09 (study day 212); relationship: Y

moderate assessed 2026-08-18

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-12-30 (study day 233); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-04-04 (study day 329); relationship: N

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.